Dec 20

By Scott LaFee, UNION-TRIBUNE STAFF WRITER

Rick Kneeshaw of Scripps Ranch suffered from polio as a child (inset, right). Now he is battling post-polio syndrome, a disease that can strike former polio victims decades after they have recovered from the initial disease.

Earnie Grafton / Union-Tribune

Rick Kneeshaw of Scripps Ranch suffered from polio as a child (inset, right). Now he is battling post-polio syndrome, a disease that can strike former polio victims decades after they have recovered from the initial disease.

In 1950, when he was 31?2 years old, Rick Kneeshaw contracted polio.

Within days, the healthy toddler was crippled, paralysis quickly numbing and immobilizing his left leg, hip and parts of his back. Over the next 12 years, Kneeshaw would endure many operations, each attempting to restore at least partial muscle and nerve function. Between surgeries, Kneeshaw would spend hours in physical therapy, going and growing through countless braces, crutches and other supports.

“By the time I was 16, I figure I’d spent a quarter of my life in hospitals,” he said.

The payoff was partial recovery. He was able to walk without braces or crutches — at least on level surfaces for short distances. “It gave me nighttime mobility at least. I could get out of bed, go to the bathroom. That was something.”

But something changed in 1971. At age 25, Kneeshaw’s joints on his polio-damaged left side began to ache and act up, forcing him to resume wearing a leg brace. He would never again be without it. He took up using crutches again. And in 1984, his right leg — the healthy one — began to progressively weaken. It got to the point where he could only stand for brief periods. He began using a wheelchair.

Kneeshaw knew he had never actually conquered polio, but he thought he had put it behind him. He had moved on, becoming an electrical engineer, marrying, having children. Polio caught up.

In the late 1940s and 1950s, paralytic poliomyelitis was a scourge and nightmare, the most terrifying public health threat in post-World War II America. The causative agent — a virus that inhabits the gastrointestinal tract — had been identified only a few decades earlier. It was extraordinarily infectious, easily transmitted via contaminated food or water. Epidemics were annual occurrences, each seemingly worse than the last. By 1952, polio was killing more Americans than any other communicable disease: More than 300,000 cases and 58,000 deaths in that year alone. Most of the victims were children, their young immune systems unprepared for the viral onslaught.

After infecting a body and incubating for several days in gastrointestinal cells, the poliovirus spreads along key nerve fiber pathways, replicating in and destroying motor neurons in the spinal cord and brain stem. With their nerve connections destroyed, affected muscles atrophy from lack of stimulation, weakening until permanent paralysis sets in. The damage can be limited to a single finger joint or affect almost the entire body. During one of his stays in a hospital ward occupied entirely by teens with polio, Kneeshaw recalls a girlfriend who was completely paralyzed except for her left arm.

To be sure, the majority of infected children escaped relatively unscathed, acquiring lifelong immunity while suffering only temporary, flu-like symptoms or no symptoms at all. But a small percentage were devastated, the disease exacting permanent, crippling damage. In the worst cases, the virus destroyed motor neurons that control breathing. Many of these polio victims, if they survived, spent the rest of their shortened lives inside “iron lungs” — ungainly, tubular tanks that inflated and deflated their paralyzed lungs by alternating air pressure inside the device.

The polio vaccine, developed by Jonas Salk and introduced in 1955, profoundly changed the equation. The Salk vaccine, which used a killed virus to generate immunity, and a subsequent oral vaccine developed by Albert Sabin (using an attenuated live virus), dramatically reduced the incidence of polio in the United States. New cases declined to less than 1,000 in 1962 and just 121 in 1964. The last reported case of “wild polio” in the United States occurred in 1979. The infrequent infections reported since have all been imported cases or the result of a rare immunological response to the vaccine, which remains one of the major inoculations of childhood.

It’s estimated that up to 600,000 Americans today once had polio. Many are like Kneeshaw, “polio survivors” who labored to rebound from the disease. With treatments and hard work, their bodies overcame at least some of the effects of polio. Motor neurons that survived the initial infection sprouted new and additional fibers, extending into damaged areas to restore at least limited muscle function.

Such was the case with Nan Kaufman, who was 6 years old and living in Texas when she came down with polio in 1954. Her parents thought she had a bad case of the flu until Kaufman collapsed on the way to the doctor, suddenly unable to stand or walk. The disease permanently disabled her right side, stunting growth in her arm and leg, though Kaufman learned to compensate and to persevere.

“I was pretty determined to do what I wanted to do, which was be like other children,” she said. “I learned to ride a bike. I ran, even though my right leg was thinner and shorter. I swam competitively, even though my right hand and arm were chronically weak. There was a good deal of denial and magical thinking. People with polio often become overachievers.”

Kaufman, who now lives in Point Loma, became a pediatrician. She retired in 2006 after years of escalating pain, weakness and fatigue convinced her that she could no longer do her job effectively or safely. “It’s hard to say when symptoms first emerged. I had spent my life pushing pretty hard, raising four children, working long hours as a doctor. I had always had bad days, but I thought it was just that I was tired. Then I started having trouble with my ankle. I fell a lot. I dropped things. I became afraid I might one day drop a baby.”

Kaufman saw doctor after doctor, but no one could pinpoint the problem. She worried she had amyotrophic lateral sclerosis (ALS) or Lou Gehrig’s disease, a progressive and fatal neurodegenerative disease that destroys voluntary muscle control. A neurologist finally identified the real problem: post-polio syndrome. Like Kneeshaw, an old nemesis had come back.

Very little is known about post-polio syndrome, or PPS. No one knows why the condition seems to emerge 30 to 40 years after the original infection. The working hypothesis is that years of overcompensation takes its toll, that surviving, functional, motor neurons and muscles are overworked and simply begin to wear out and shut down. There is evidence that people who had milder cases of polio, who had more surviving motor neurons, are at greater risk of developing PPS than those who suffered significant, permanent damage.

“People who essentially had no recovery from the original polio are much less likely to have PPS symptoms than those with good recovery,” said Dr. Susan Perlman, a neurologist at the University of California Los Angeles.

It is confoundingly difficult to identify PPS. Symptoms such as fatigue, breathing difficulties and muscle weakness tend to be subtle and gradual. They may be associated with many other conditions, from simple exhaustion to other serious neurodegenerative diseases. The situation is further complicated by likely pre-existing health problems and aging.

“Remember, this condition arises in the context of someone who has probably already suffered some degree of paralysis or disability for most of their lives, so it can be hard to separate new symptoms from old ones,” said Dr. Sam Pfaff, a neurobiologist at the Salk Institute for Biological Studies in La Jolla. “Plus, the syndrome is superimposed upon the aging process.”

It doesn’t help that most doctors have never treated an active case of polio or that there’s no definitive diagnostic test.

“There are no biomarkers,” said Pfaff. “Identifying the condition means doing a careful work-up of the patient, knowing and understanding the patient’s history. Post-polio syndrome is the answer you get after you’ve excluded all other possibilities.”

There is no cure for PPS. Treatment consists of ameliorating symptoms and limiting circumstances and behaviors that can accelerate or exacerbate health problems. “The only thing you can do to prevent the disease from progressing is to pace yourself,” said Kaufman. “Telling yourself to push through it, to just get on with life, only makes it worse.”

Not surprisingly, people like Kaufman and Kneeshaw, who was actually a poster child for anti-polio efforts in the 1950s, are strong advocates for more and better research into PPS. They would like to see new therapies, a cure if possible. But they also recognize a harsh reality: Theirs is an affliction that strikes only a distinct and shrinking population of people, particularly in the United States. Unless polio re-emerges as a major public health threat, post-polio syndrome will inevitably decline and disappear as polio survivors do the same.

“We’re a dying breed,” said Gladys Swensrud, who got polio as a 3-year-old living in Escondido in 1951 and now suffers from muscle weakness and breathing problems that require her to use a respirator at night when sleeping.

Swensrud would like to feel better. She argues, as do others with PPS, that it is shortsighted and foolish to simply (and cruelly) write off post-polio syndrome as a health problem that will solve itself as PPS patients pass away. Pfaff at the Salk Institute agrees:

“Polio is not a big public health problem anymore, but it hasn’t been completely eliminated. There are still occasional outbreaks in other parts of world, particularly Africa and Asia. There are thousands of other polio survivors in the world.”

A better understanding of PPS could improve treatments and ease the burden upon survivors around the world. It might also fill in knowledge gaps about the basic biology and pathology of the human body, providing “information that’s relevant to other neurological diseases and other biological systems.”

And that, said Kneeshaw, sitting in his wheelchair, is always a step in the right direction.

Original here

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • del.icio.us
  • Wists
  • Fark
  • Furl
  • Ma.gnolia
  • Netscape
  • NewsVine
  • Reddit
  • Spurl
  • StumbleUpon
  • YahooMyWeb
  • Technorati
Dec 20

(HealthDay News) — Young adults who have casual sex are no more likely than those in committed relationships to experience psychological problems, new research has found.

In the study, University of Minnesota researchers analyzed the responses of 737 females and 574 males, mean age 20.5, who were asked about their sexual behaviors and emotional well-being. Among those who were sexually active, 55 percent said their last sexual partner was an exclusive dating partner. An additional 25 percent said they were engaged to, or a spouse or life partner of their last sexual partner. Another 12 percent said it was a close but not exclusive partner, and 8 percent said it was a casual acquaintance.

More than twice as many males as females said their last sexual partner was a casual acquaintance or a close but not exclusive partner, the study authors noted.

In this study to determine if sexual activity outside a committed relationship causes emotional damage to young people, the researchers found no differences in the mental well-being of participants who had a casual partner or a committed partner.

“While the findings from this study show that young adults engaging in casual sexual encounters do not appear to be at increased risk for harmful psychological outcomes compared to those in more committed relationships, this should not minimize the legitimate threats to physical well-being associated with casual sexual relationships, and the need for such messages in sexuality education programs and other interventions with young adults,” study author Marla E. Eisenberg, of the University of Minnesota Medical School, said in a university news release.

 Original here

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • del.icio.us
  • Wists
  • Fark
  • Furl
  • Ma.gnolia
  • Netscape
  • NewsVine
  • Reddit
  • Spurl
  • StumbleUpon
  • YahooMyWeb
  • Technorati
Sep 17

rx.jpg
julianayrs.com
You can’t argue with results.

“There’s no proof that medical marijuana works. It needs more study. There’s only anecdotal evidence. It doesn’t treat specific conditions. People just want to get high.” Every cannabis advocate and medical marijuana patient has run into these arguments, threadbare as they are in 2009. Even from professionals who should know better — such as many medical doctors — the same tired arguments come up again and again.As baffling as it may be, just listening to the patients (what a concept!) isn’t considered “proof” by the medical establishment, which considers such evidence interesting, but “merely” anecdotal.
But after a new groundbreaking round-up clinical evidence for the efficacy of medical pot, however, such misconceptions are going to be a lot easier to shoot down.

In the landmark article, published in the Journal of Opioid Management, University of Washington researcher Sunil Aggarwal and colleagues document no fewer than 33 controlled clinical trials — published over a 38-year period from 1971 to 2009 — confirming that marijuana is a safe, effective medicine for specific medical conditions.
“The most common misconception among doctors and the general public regarding medical marijuana is that its effectiveness claims are substantiated only by compelling anecdotes from patients,” Aggarwal told SF Weekly. “What is not acknowledged is that 33 separate controlled clinical trials with patients —  at least a third of which are of gold standard design — have been conducted and published in the United States by investigators at major research centers using the same federal cannabis supply and mode of delivery.”In fact,” Aggarwal and colleagues write, “nearly all of the 33 published controlled clinical trials conducted in the United States have shown significant and measurable benefits in subjects receiving the treatment.”

571px-Seattle_Hempfest_2007_-_Sunil_Aggarwal_02A.jpg
Photo by Joe Mabel
Dr. Sunil Aggarwal: The results are in.

Additionally, the article documents the growing acceptance of the therapeutic use of marijuana among organized medicine groups. More than 7,000 American physicians (in the 13 states where medical marijuana is legal) have signed medical marijuana authorizations for a total of 400,000 patients, according to Aggarwal and colleagues.

Notably absent from medical marijuana patients in the published trials — and in glaring contrast to opiate drugs — are withdrawal symptoms and other signs of drug dependence. Adverse effects were relatively rare, and “the vast majority of reported adverse effects were not serious… It is clear that as an analgesic, cannabis is extremely safe with minimal toxicity.”

Unfortunately, ignorance regarding marijuana still remains widespread, even in the medical community, according to the article. “There remains a near complete absence of education about cannabinoid medicine in any level of medical training,” Aggarwal writes.

“This is arguably the most thorough review of the literature on medical marijuana since the Institute of Medicine report over a decade ago, with a trove of data that wasn’t available to the IOM,” said Rob Kampia, executive director of the Marijuana Policy Project, which works for legalization. “It is simply incomprehensible that a medicine that is so clearly safe and effective remains banned from medical use by federal law and the laws of 37 states.”

Under current federal law, marijuana is classified as a Schedule I drug, defining it as having high potential for abuse, unsafe for use even under medical supervision, and lacking currently accepted uses in the U.S.

The article, “Medicinal Use of Cannabis in the United States: Historical Perspectives, Current Trends, and Future Directions,” is available here (PDF).

Aggarwal offers a complete list of the 33 U.S. clinical trials; contact him here.

Original here

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • del.icio.us
  • Wists
  • Fark
  • Furl
  • Ma.gnolia
  • Netscape
  • NewsVine
  • Reddit
  • Spurl
  • StumbleUpon
  • YahooMyWeb
  • Technorati
Sep 17

By Neil Tweedie

Happiness - the new currency in France

French president Nicolas Sarkozy says we should change the way we measure national wellbeing Photo: GETTY

The French, let’s face it, are hardly a barrel of laughs. Take their cinema: morose man stares at morose woman; morose woman stares back at morose man. Gauloise smoke coils lazily between them as they survey their mutual desolation. Fin.

As for their waiters – well, need one expand?

Yes, the French are good at looking miserable, and, at the moment, they have something to be miserable about. Last week, François Fillon, the prime minister of France, warned that chronically slow growth threatened not only his country’s cherished “social model” but the very survival of the economy itself. France, like Britain, is bumping along the bottom of the downturn: growth in GDP is expected to be one per cent next year, half that of the United States and a quarter of that in Asia. Unemployment, meanwhile, is nearing 10 per cent. The country is sliding steadily down the league table of economic performance. When purchasing power parity is used, her economy is now eighth in the world, behind Russia and just in front of Brazil. Not a pretty picture – which is why Nicolas Sarkozy has decided to get out his paint set and brighten things up.

Gross domestic product, inflation, unemployment, these are old-fashioned, Anglo-Saxon indicators of national wellbeing, says the president of France. From now on, the country’s economic progress will be measured in terms of happiness – bonheur. And how does one measure bonheur? Well, through things like work-life balance, rates of recycling and traffic congestion. And DIY.

The president is taking his lead from a report he commissioned last year from two Nobel Prize-winning economists, the American Joseph Stiglitz and India’s Amartya Sen, who concluded that new indexes are needed to measure wellbeing and environmental sustainability. Endorsing the report, President Sarkozy said: “The [banking] crisis doesn’t only make us free to imagine other models, another future, another world. It obliges us to do so.” France would put pressure on international organisations to revise their statistical methods to reflect this new reality. So is this merely a form of Gallic mickey-taking, like the Common Agricultural Policy, or is there something to the concept of “gross national happiness”?

Rating countries by the contentment of their populations is a new and questionable pursuit. Two years ago, the British academic Adrian White published a league table of happiness which put Denmark in pole position, ahead of the United States (23) and Britain (41). White combined figures compiled by Unesco, the World Health Organisation and the CIA with responses from 80,000 people in 178 countries. He found that when it came to happiness, factors such as health care and education were significant – hardly a revelation.

A “Happiness Index” produced earlier this year by the British think-tank New Economic Foundation used criteria such as life expectancy and the “ecological footprint” of the population. Costa Rica came top, while in sixth place was Colombia – quite an achievement for a country previously noted for the efficiency of its death squads. Lord Layard, the academic, government “happiness tsar” and author of a book on the subject, is convinced that such exercises are worthwhile.

“The French report was conceived before the downturn, so it is not a diversionary tactic at all,” he says. “We can measure happiness. A good way is simply by asking people – and you find those answers are very well correlated with electrical activity in the relevant parts of the brain. There is a completely coherent story about how to measure whether people are feeling good or bad, and what causes them to feel good or bad.”

The French report points to the importance of relationships in overall happiness - do you have enough time to meet your friend/wife/mistress etc.

“Relationships are a lot more important than is normally allowed for,” says Lord Layard. “If we want to achieve a higher level of happiness – and it has been more or less static for the past 50 years – we have got to pay a lot more attention to relationships and not be so willing to sacrifice them for the sake of greater income or productivity.”

The French have already bucked the Anglo-Saxon preference for long working days and “face time” in the office, introducing a statutory 35-hour hour working week, observed by 86 per cent of the salaried population. “In many ways, French society is a better organised one than ours,” says Lord Layard. “Their productivity is about 20 per cent higher than ours, and has been for a very long time. Their working week has always been shorter, and they have always enjoyed longer holidays.”

He believes that a concentration on materialism and status at the expense of family and wider relationships has contributed to the failure of collective happiness – or “subjective wellbeing” – to keep pace with economic growth.

“One factor is that satisfaction in marriage has gone down,” says Lord Layard. “There has been a long-term increase in family tension. We are still going through a very long process of adaptation in which women have fewer children and seek, absolutely rightly, some other meaning in life through work. There is a huge social pressure to increase income – everyone is running on the spot to keep up with everyone else.”

Once a society reaches a per capita income of just over £10,000, people stop getting happier simply by earning greater and greater amounts of money. One’s position in the food chain then begins to take over. Research carried out by the University of Bonn has shown that the pain of earning less than one’s colleague is felt more keenly than the pleasure of earning more.

Bruno Frey, a researcher at Zurich University, calls this dulling process in regard to greater wealth “hedonic adaptation”. “People rapidly adjust to increases in income,” he says. “After about one year, two-thirds or more of the benefits of an increase in income wear off as people increase their income aspirations. This process has become known as the aspirational treadmill.”

According to Frey, using happiness as an indicator of national progress is dangerous. Governments will be tempted to distort responses to create a rosier picture, while respondents may be tempted to give less than honest answers.

“When individuals become aware that the happiness level they report influences the behaviour of political actors, they have an incentive to misrepresent it. They can play the system.”

The French report may also be looking at the wrong indicators. The ability of mothers to spend more time with their children may not be a key factor for some.

No doubt Sarkozy’s statisticians will come up with the figures he needs. Gender equality in terms of pay is one proposed indicator, and France does not do too badly there. There is a headline 20 per discrepancy in male-female remuneration, but when people of the same seniority and experience are compared, the differential falls to six per cent.

Gerard Mermet, author of Francoscopie, a survey of French national life published every two years, backs Sarkozy. “It is not possible to understand the world without qualitative indicators,” he says. “GDP is simply not sufficient.”

But what worries your average mec? “Unemployment – and growing inequality in wages. The French are also suspicious of the morality of big bosses, their big salaries. Suspicion of inequality is probably written in human nature but maybe a little more in French nature.”

His countrymen, he says, may adopt a morose attitude to the world at large but are sensible enough to recognise their own good fortune. “If you ask the French, they always say France is not doing very well, but when you ask them about themselves individually, they are happy. The world is bad, France is bad but my own life is not bad.”

Sarkozy may get the answer he is looking for – but maybe not. John Stuart Mill warned: “Ask yourself whether you are happy and you cease to be so.”

Original here

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • del.icio.us
  • Wists
  • Fark
  • Furl
  • Ma.gnolia
  • Netscape
  • NewsVine
  • Reddit
  • Spurl
  • StumbleUpon
  • YahooMyWeb
  • Technorati